首页> 外文期刊>Journal of pharmaceutical sciences. >Quality-by-Design (QbD): an integrated process analytical technology (PAT) approach for real-time monitoring and mapping the state of a pharmaceutical coprecipitation process.
【24h】

Quality-by-Design (QbD): an integrated process analytical technology (PAT) approach for real-time monitoring and mapping the state of a pharmaceutical coprecipitation process.

机译:设计质量(QbD):一种集成的过程分析技术(PAT)方法,用于实时监测和绘制药物共沉淀过程的状态。

获取原文
获取原文并翻译 | 示例
           

摘要

In this work, an integrated PAT approach was developed for monitoring a pharmaceutical (naproxen) and a polymer (eudragit) coprecipitation process: real-time in-line near-infrared (NIR) absorbance monitoring, real-time on-line turbidity monitoring, and in situ crystal size monitoring. The data and information obtained through these three monitoring techniques confirmed the observation of the onsets of three distinct stages: incubation, nucleation, and crystal growth. The process trajectory constructed based on results of applying principal component analysis (PCA) to either process NIR spectra data or process turbidity profile, clearly demonstrated that various distinguishable process events, including incubation, nucleation, and crystal growth, could be accurately tracked and differentiated. These findings were further supported by process knowledge and information, such as process design, process sequence, thermodynamic and mass-transfer analysis. Therefore, this work provides a case study that illustrated a rational approach to develop a science-based and knowledge-based process monitoring strategy, which is essential for establishing both a suitable process control strategy and an operational process space for a pharmaceutical unit operation.
机译:在这项工作中,开发了一种集成的PAT方法来监视药物(萘普生)和聚合物(eudragit)的共沉淀过程:实时在线近红外(NIR)吸光度监控,实时在线浊度监控,和原位晶体尺寸监控。通过这三种监测技术获得的数据和信息证实了对三个不同阶段发病的观察:孵化,成核和晶体生长。基于将主成分分析(PCA)应用于过程NIR光谱数据或过程浊度曲线的结果而构建的过程轨迹清楚地表明,可以准确地跟踪和区分各种可区分的过程事件,包括孵育,成核和晶体生长。这些发现得到了过程知识和信息的进一步支持,例如过程设计,过程顺序,热力学和传质分析。因此,这项工作提供了一个案例研究,说明了开发基于科学和基于知识的过程监视策略的合理方法,这对于建立合适的过程控制策略和制药部门运营的操作过程空间至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号